Antiviral therapy
-
To characterize the value of total lymphocyte counts in predicting risk of death among patients initiating triple combination antiretroviral therapy. ⋯ Total lymphocyte count may provide a simple and cost-effective alternative for prioritizing therapy initiation in resource-limited settings. Our results suggest that, if appropriately validated, judicious application of total lymphocyte counts could overcome one of the practical obstacles to more widespread provision of antiretroviral therapy in resource-poor settings.